WO2000039562A1 - Analyse de vitamines par spectroscopie proche infrarouge - Google Patents
Analyse de vitamines par spectroscopie proche infrarouge Download PDFInfo
- Publication number
- WO2000039562A1 WO2000039562A1 PCT/EP1999/010502 EP9910502W WO0039562A1 WO 2000039562 A1 WO2000039562 A1 WO 2000039562A1 EP 9910502 W EP9910502 W EP 9910502W WO 0039562 A1 WO0039562 A1 WO 0039562A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- vitamins
- near infrared
- composition
- spectrum
- Prior art date
Links
- 229940088594 vitamin Drugs 0.000 title claims abstract description 92
- 229930003231 vitamin Natural products 0.000 title claims abstract description 92
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 92
- 239000011782 vitamin Substances 0.000 title claims abstract description 92
- 238000012845 near infrared spectroscopy analysis Methods 0.000 title description 3
- 239000000203 mixture Substances 0.000 claims abstract description 62
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 45
- 238000001228 spectrum Methods 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 14
- 238000002329 infrared spectrum Methods 0.000 claims description 11
- 238000004497 NIR spectroscopy Methods 0.000 claims description 10
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- 235000009492 vitamin B5 Nutrition 0.000 claims description 6
- 239000011675 vitamin B5 Substances 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 235000019742 Vitamins premix Nutrition 0.000 claims description 5
- 238000003908 quality control method Methods 0.000 claims description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 238000004566 IR spectroscopy Methods 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 description 20
- 239000007787 solid Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000011088 calibration curve Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003571 Vitamin B5 Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000012711 vitamin K3 Nutrition 0.000 description 2
- 239000011652 vitamin K3 Substances 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000020795 whole food diet Nutrition 0.000 description 2
- WZSDWSACAGBYQU-UHFFFAOYSA-N 2-(dimethylamino)-3-phenylprop-2-enal Chemical compound CN(C)C(C=O)=CC1=CC=CC=C1 WZSDWSACAGBYQU-UHFFFAOYSA-N 0.000 description 1
- 241001634822 Biston Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 238000012630 chemometric algorithm Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004860 thiamine mononitrate Drugs 0.000 description 1
- 235000019191 thiamine mononitrate Nutrition 0.000 description 1
- 239000011748 thiamine mononitrate Substances 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 238000000411 transmission spectrum Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3563—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing solids; Preparation of samples therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3577—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing liquids, e.g. polluted water
Definitions
- the present invention relates to a novel process for the qualitative and quantitative analytical determination of a vitamin or a mixture of vitamins and in particular to a process for the qualitative and quantitative determination of vitamins using near infrared spectroscopy .
- premixes intended for animal feed can be in the form of liquid mixtures or in a solid form.
- the vitamin premix when it is in the liquid form, it often contains diluents, surfactant and stabilisers.
- the premix When the premix is in solid form, the composition often contains a support for example of mineral or plant origin, as well as food additives such as amino acids and/or vitamins. After preparation of the premix, it is preferable to check the composition and/or homogeneity of these mixtures by means of a rapid and non-destructive analytical technique.
- Zootech (1993) 42, 251-270 who established calibration curves for the following analyses: solids content, ash content, total proteins, water-soluble carbohydrates, celluloses, cell wall constituents, total fibres, acidic and neutral detergent fibres, lignin, enzymatic solubilities determined by the Aufrere, Limagrain and Lila methods.
- This combination of "in vitro" analyses has made it possible to carry out near-infrared analyses and, with the aid of a statistical analysis, to establish correlation curves which henceforth allow a direct near-infrared spectroscopy determination of the digestibility value "in vivo".
- the present application provides a method for the determination of the presence of one or more vitamins in a composition containing the vitamin characterised in that the presence is determined by near infrared spectroscopy.
- the method comprises
- step (e) comparing the spectrum obtained in step (d)with the spectra of the data base to identify the vitamin and determining the concentration of vitamin from the collaboration plot.
- the presence is meant the identity of the vitamin and the amount of the vitamin.
- near infrared is meant the region of the spectrum ranging from 700 to 2500 nm.
- the present invention relates to a novel method for the direct determination of the presence of one or more vitamins in a composition containing at least one vitamin.
- the method relates in general to the direct determination of the emission or transmission spectrum of the composition containing the vitamin in the near-infrared range and then in applying chemometric algorithms to the spectrum in order to determine the vitamin concentration.
- the present method is generally not affected by the presence of the matrix in the composition even if the composition is a complex mixture, such as the various liquid supports containing the mixture of vitamins or the various solid supports constituting the basic vitamin premix to which the vitamins are added.
- the present invention is a non- invasive technique which avoids the need to extract the vitamins, which always carries uncertainty regarding the quality of the extraction, and avoids the need to undertake subsequent reactions which consume time and thus money.
- the subject of the present invention is the qualitative and/or quantitative determination of the presence of vitamins which may be in a liquid or solid vitamin complex; a mixture of vitamins and/or in a vitamin premix which, in this case also, may be liquid or solid, this complex or mixture being intended to be incorporated into whole foods for man or feeds for rearing animals, by near-infrared spectroscopy.
- the method of the present invention is used to determine the presence of at least one vitamin in a vitamin-containing composition.
- the method is particularly suitable for the determination of vitamin E or tocopherol in esterified form (acetate) , vitamin B5 or calcium D-pantothenate, vitamin D3 or cholecalciferol, vitamin PP or niacin in the acid or amide form, vitamin BI or thiamine mononitrate, vitamin B2 or riboflavin, vitamin B6 or pyridoxine hydrochloride, vitamin H or biotin, vitamin B12 or cyanocobalamin, vitamin C or ascorbic acid, vitamin A or retinol in esterified form (acetate, palmitate or propionate) , vitamin K3 or menadione and vitamin B9 or folic acid.
- the method of determination may be applied to a composition containing an individual vitamin or to a composition comprising a mixture of vitamins.
- the composition may comprise a liquid and/or solid support which may be liquid or solid.
- the support used in the solid premixes can be chosen from supports of mineral or plant origin.
- the mineral supports which may be mentioned are calcium carbonate, dicalcium phosphate and sodium chloride.
- the plant supports which may be mentioned in a non-limiting manner, are wheat or rice bran, middlings, soya cake and corn husks.
- These premixes can also contain microelements such as iron, cobalt, copper, manganese, molybdenum, selenium and zinc salts with various hydration contents.
- the method of the present invention comprises the creation of a data base. This procedure involves the accumulation of chemical analytical data for a number of known proteins and/or protein mixtures.
- the method for chemical determination of the vitamin consists in carrying out a conventional chemical analysis of a population of representative samples of the variation range in terms of composition which may be expected in practice. For reasons of statistical reliability, a minimum of 80, preferably at least 120 samples may be used to start the construction of such a type of mathematical model .
- the corresponding near infrared spectrum for each sample is recorded by means of a spectrophotometer working in the near-infrared range (i.e. between 700 and 2500 nm) .
- the measurement taken is in the form of a spectrum which in fact bears information regarding the physicochemical composition of the sample.
- the two sets of results are recorded and stored, thus establishing a database of the results obtained by chemical analysis and the absorbance values measured by near infrared spectroscopy.
- a calibration plot is then prepared, by mathematical processing of the infra red spectroscopy data, using appropriate computer software.
- the mathematical processing provides a linear regression which makes it possible to establish a prediction curve.
- the management of these operations can be carried out by means of any suitable commercially available software system.
- the accuracy of the relationship between the near infrared analysis and the chemical analysis may be verified by recording the spectrum of samples of vitamin of known concentration using samples which have not been used to establish the calibration curve.
- the results obtained after the mathematical treatment may be compared with the calibration curve.
- the next step of the method of the present invention comprises recording the infra red spectrum of the vitamin-containing composition.
- the spectrum, thus obtained is compared with the spectra stored in the date base.
- the spectrum, thus obtained is subjected to the same mathematical treatment as the calibration samples to provide a number. As proven from the calibration plot, this number corresponds to the concentration of vitamin.
- the quality control method may be carried out by the vitamin manufacturer or the breeder.
- Step 1 Construction of a calibration population
- a calibration population of 120 samples of vitamin-containing compositions was prepared which involved the preparation of data base of chemical analysis results and near infrared spectra.
- the chemical analysis of the vitamin- containing composition was carried out for each sample as per the standard routine analysis for the particular vitamin to qualitatively and quantitatively identify either the vitamin and/or the vitamins in the composition
- the samples were also analysed using near infra red spectroscopy wherein the spectrum of each sample was obtained in the region of 700 to 2500nm.
- the spectrum of each sample was recorded using a grating spectrophotometer of NIRS 6500 type (sold by FOSS Int.) operating in "reflectance" mode.
- NIRS 6500 type sold by FOSS Int.
- a particular specificity of the instrument was that it worked over the entire near-infrared range rather than over a number of specific wavelengths, as is the case for certain more conventional machines .
- the sample was packaged in a rectangular transportation cell composed of three opaque faces and a face fitted with a quartz crystal. After positioning the cell in the spectrophotometer, the light reflected by the sample, which bears information regarding the chemical composition of this sample, was recorded in the form of a spectrum. Each type of product, and consequently each sample, has a different spectrum.
- the results from the chemical and spectroscopic analyses were stored in a data base and identified as the calibration file. The calibration file thus contained a combination of numerical and spectral data.
- the entire calibration file constructed was subjected to a statistical calculation using suitable software (NIRS 2, version 3.00 distributed by Infrasolt International I.S.I.) which made it possible to detect the presence of non-standard spectra which have excessively large Mahalanobis distances (statistical distance H) compared with the average spectrum of the population (centre of gravity) . Once detected, these samples were eliminated in order to obtain homogeneous population.
- suitable software NIRS 2, version 3.00 distributed by Infrasolt International I.S.I.
- the calibration file containing all the samples was then subjected to a statistical analysis, of which three different types exist: "Modified Partial Least Square” (MPLS), Partial Least Square (PLS), which is a general form of regression by main components, or “step up", which corresponds to a simpler linear regression.
- MPLS Modified Partial Least Square
- PLS Partial Least Square
- step up which corresponds to a simpler linear regression.
- Figures 1/6 to 4/6 show, respectively, the calibration curves for vitamins A, E, B5 and PP in vitamin mixtures
- Figures 5/6 to 6/6 represent calibration curves for vitamins E and A established on food premixes on an organic support containing various mineral salts.
- the near infrared spectrum of the unknown sample was recorded and entered into the data base to find a corresponding spectrum.
- the vitamin was therefore identified qualitatively.
- the spectrum was subjected to the same statistical calculation as the database samples to obtain a figure which corresponds to the concentration of the vitamin as verified by the calibration.
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU21047/00A AU2104700A (en) | 1998-12-23 | 1999-12-22 | Near infrared spectroscopic analysis of vitamins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9816362 | 1998-12-23 | ||
FR98/16362 | 1998-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000039562A1 true WO2000039562A1 (fr) | 2000-07-06 |
Family
ID=9534431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/010502 WO2000039562A1 (fr) | 1998-12-23 | 1999-12-22 | Analyse de vitamines par spectroscopie proche infrarouge |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2104700A (fr) |
WO (1) | WO2000039562A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102058682A (zh) * | 2009-11-17 | 2011-05-18 | 天津天士力现代中药资源有限公司 | 一种白芍提取液中的芍药苷含量的nir在线检测方法 |
CN102636449A (zh) * | 2011-06-15 | 2012-08-15 | 江西本草天工科技有限责任公司 | 一种近红外光谱测定白芍提取过程中芍药苷含量的方法 |
CN111896604A (zh) * | 2020-06-05 | 2020-11-06 | 中芯维康医疗科技(重庆)有限责任公司 | 一种维生素检测仪质控品组合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5506117A (en) * | 1989-10-18 | 1996-04-09 | Cytokinetics, Inc. | Biochemical process for growing living cells by measuring the amount of nutrient added to the reaction medium |
WO1997021091A1 (fr) * | 1995-12-01 | 1997-06-12 | Commonwealth Scientific And Industrial Research Organisation | Procede d'evaluation de la qualite d'aliments pour animaux |
DE29809591U1 (de) * | 1997-09-04 | 1998-09-24 | Basf Ag, 67063 Ludwigshafen | Vorrichtung zur Identifizierung von Wirkstoffen |
-
1999
- 1999-12-22 WO PCT/EP1999/010502 patent/WO2000039562A1/fr active Application Filing
- 1999-12-22 AU AU21047/00A patent/AU2104700A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5506117A (en) * | 1989-10-18 | 1996-04-09 | Cytokinetics, Inc. | Biochemical process for growing living cells by measuring the amount of nutrient added to the reaction medium |
WO1997021091A1 (fr) * | 1995-12-01 | 1997-06-12 | Commonwealth Scientific And Industrial Research Organisation | Procede d'evaluation de la qualite d'aliments pour animaux |
DE29809591U1 (de) * | 1997-09-04 | 1998-09-24 | Basf Ag, 67063 Ludwigshafen | Vorrichtung zur Identifizierung von Wirkstoffen |
Non-Patent Citations (1)
Title |
---|
HANCEWITCZ T. M. AND PETTY C.: "Quantitative analysis of vitamin A using Fourier transform Raman spectroscopy.", SPECTROCHIMICA ACTA PART A, vol. 51, 4 May 1995 (1995-05-04), pages 2193 - 2198, XP002115781 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102058682A (zh) * | 2009-11-17 | 2011-05-18 | 天津天士力现代中药资源有限公司 | 一种白芍提取液中的芍药苷含量的nir在线检测方法 |
CN102636449A (zh) * | 2011-06-15 | 2012-08-15 | 江西本草天工科技有限责任公司 | 一种近红外光谱测定白芍提取过程中芍药苷含量的方法 |
CN111896604A (zh) * | 2020-06-05 | 2020-11-06 | 中芯维康医疗科技(重庆)有限责任公司 | 一种维生素检测仪质控品组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
AU2104700A (en) | 2000-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wahl et al. | PAT for tableting: Inline monitoring of API and excipients via NIR spectroscopy | |
Stark et al. | Near-infrared analysis (NIRA): A technology for quantitative and qualitative analysis | |
Pérez-Marı́n et al. | Near-infrared reflectance spectroscopy (NIRS) for the mandatory labelling of compound feedingstuffs: chemical composition and open-declaration | |
Saeys et al. | Potential for onsite and online analysis of pig manure using visible and near infrared reflectance spectroscopy | |
El-Hagrasy et al. | A process analytical technology approach to near-infrared process control of pharmaceutical powder blending. Part III: quantitative near-infrared calibration for prediction of blend homogeneity and characterization of powder mixing kinetics | |
Blanco et al. | Identification and quantitation assays for intact tablets of two related pharmaceutical preparations by reflectance near-infrared spectroscopy: validation of the procedure | |
Dixit et al. | Evaluating the performance of a miniaturized NIR spectrophotometer for predicting intramuscular fat in lamb: A comparison with benchtop and hand-held Vis-NIR spectrophotometers | |
Blanco et al. | Simultaneous quantitation of five active principles in a pharmaceutical preparation: Development and validation of a near infrared spectroscopic method | |
Dou et al. | Artificial neural network for simultaneous determination of two components of compound paracetamol and diphenhydramine hydrochloride powder on NIR spectroscopy | |
Igne et al. | Modeling strategies for pharmaceutical blend monitoring and end-point determination by near-infrared spectroscopy | |
Pierna et al. | NIR fingerprint screening for early control of non-conformity at feed mills | |
Blanco et al. | Development and validation of a method for the analysis of a pharmaceutical preparation by near‐infrared diffuse reflectance spectroscopy | |
Bodson et al. | Comparison of FT-NIR transmission and UV–vis spectrophotometry to follow the mixing kinetics and to assay low-dose tablets containing riboflavin | |
US20190369013A1 (en) | Method and apparatus for spectroscopic analysis, implementing infrared and fluorescence multichannel processing of spectral data | |
Belanche et al. | Estimation of feed crude protein concentration and rumen degradability by Fourier-transform infrared spectroscopy | |
Blanco et al. | Preparing calibration sets for use in pharmaceutical analysis by NIR spectroscopy | |
Blanco et al. | Development and validation of a near infrared method for the analytical control of a pharmaceutical preparation in three steps of the manufacturing process | |
Volmer et al. | Infrared analysis of urinary calculi by a single reflection accessory and a neural network interpretation algorithm | |
Blanco et al. | Near-infrared analytical control of pharmaceuticals. A single calibration model from mixed phase to coated tablets | |
Puig-Bertotto et al. | Evaluation of a handheld near-infrared spectrophotometer for quantitative determination of two APIs in a solid pharmaceutical preparation | |
Riccioli et al. | Pixel selection for near-infrared chemical imaging (NIR-CI) discrimination between fish and terrestrial animal species in animal protein by-product meals | |
Ehsani et al. | Development of a non-targeted approach using three handheld spectrometers combined with ensemble classifiers for authentication of bovine milk | |
WO2000039562A1 (fr) | Analyse de vitamines par spectroscopie proche infrarouge | |
WO2015040626A1 (fr) | Analyse quantitative des éléments constitutifs du lait | |
Reeves | Use of near infrared reflectance spectroscopy. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |